Delivery Order SPE2DB22D1017-SPE2DB25FG4BB

Award Date 6/3/25
Potential Completion Date 6/4/25
Potential Value $8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 with the Defense Logistics Agency (DLA) Troop Support Medical. The IDC provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order valued at $25,761.15 for the supply of the drug Descovy 200-25 mg Tablet. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of February 20, 2025. The contract is a Firm Fixed Price agreement and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,588.19, is for the delivery of Descovy 200-25 mg tablets. This award falls under AmerisourceBergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for...
This federal contract award to Amerisourcebergen Drug Corp is a Delivery Order valued at $10,060.14 for the supply of Descovy 200-25 mg tablet. The contract is awarded by the Defense Logistics Agency (DLA) and has an ultimate completion date of February 28, 2025. The contract is a Firm Fixed Price award, with no set-aside requirements. Amerisourcebergen, a major pharmaceutical distributor, is the prime contractor. This award is part of a larger Indefinite Delivery Contract (IDC) valued at...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Descovy 200-25 mg tablets. The $6,398.31 firm fixed-price Delivery Order was awarded by the Defense Logistics Agency (DLA), a component of the Department of Defense, on December 20, 2022, with a completion date of December 21, 2023. The award was not designated as a set-aside contract. In addition to this Delivery Order, Amerisourcebergen holds a significant $999,999,999...
The Defense Logistics Agency (DLA) awarded a Delivery Order valued at $7,307.51 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Descovy 200-25 mg tablets. This Delivery Order was issued under an Indefinite Delivery Contract (IDC) between Cencora, Inc. (doing business as Amerisourcebergen) and the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. The IDC serves as the primary vehicle for Amerisourcebergen to provide...
This federal contract award to Amerisourcebergen Drug Corp is a Delivery Order (DO) valued at $16,465.96 placed under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC). The DO is for the pharmaceutical product Descovy 200-25 mg Tablet, with a period of performance through October 10, 2024. Amerisourcebergen, a major pharmaceutical distributor and healthcare solutions provider, holds a $999,999,999 IDC with the DLA that serves as a primary vehicle for...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order worth $10,141.18 under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The award is for the pharmaceutical product "DESCOVY 200-25 MG TABLET UU 30S", with an ultimate completion date of July 2, 2024. The contract has a Firm Fixed Price pricing type and is not designated as a set-aside. Amerisourcebergen holds a...
This federal contract award, valued at $8,154.13, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $17,677.03 firm fixed-price delivery order, which does not have a set-aside designation, is for the supply of Descovy 200-25mg tablets. The contract has an ultimate completion date of August 30, 2022. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
  • SPE2DB22D1017
    Indefinite Delivery Contract
  • SPE2DB22D1017-SPE2DB25FG4BB
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, is a Delivery Order valued at $7,969.64 for the supply of Descovy 200-25 mg tablets. The contract is funded by the Defense Logistics Agency (DLA), a defense agency, and does not have a set-aside designation.

The award is associated with a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle with a performance period through December 2026. This IDC enables Amerisourcebergen to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard.

Generated 9/2/25, 9:54 AM